Drug · DIN 01926845
FLAGYSTATIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 24, 2017; first marketed December 31, 1976.
- Drug Identification Number (DIN)
- 01926845
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Vaginal
- Therapeutic class (ATC)
- Nystatin, combinations G01AA51
- Class
- Human
- Record last updated
- June 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METRONIDAZOLE | 500 MG | 4.5 G |
| NYSTATIN | 100000 UNIT | 4.5 G |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 31, 2018: NOC 20922Supplement to a New Drug Submission (SNDS) · To update the product labels and package inserts
- May 17, 2006: NOC 7972New Drug Submission (NDS) · Manufacturer name change
- October 24, 2000: NOC 1287New Drug Submission (NDS)
Other DINs named FLAGYSTATIN
- DIN 01926829 · Marketed
- DIN 01926837 · Cancelled Post Market